It was very promising in Phase I, then went in Phase 2.
More here :
thenewdaily.com.au/life/wel...
and here :
It was very promising in Phase I, then went in Phase 2.
More here :
thenewdaily.com.au/life/wel...
and here :
A reality check:
“So while it is still too early to claim definitive success, we’re doing the hard yards to discover exactly how the compound saves brain cells, and hope to report on this before the end of the year”
Obviously, they didn't find whether it actually saved brain cells, or if so, how it did it.
Besides...Who could afford the daily dose of 10-15 mgs, and even higher? Not very many.
CuATSM Compared With Placebo for Treatment of ALS/MND -- never filed final report.
Fox Foundation has a stake in it along with Procypra.